OpenSAFELY Vaccine Coverage Report
AstraZeneca / Priority Group 3
Data from combined, up to 2021-03-17.
| Vaccinated at 2021-03-17 (%) | Vaccinated at 2021-03-17 (n) | Population | Vaccinated at 2021-03-10 (%) | Vaccinated in past week (%) | ||
|---|---|---|---|---|---|---|
| Overall | - | 48.7% | 959,749 | 1,970,227 | 48.5% | 0.2% |
| Sex | Female | 48.8% | 512,568 | 1,049,650 | 48.7% | 0.2% |
| Male | 48.6% | 447,181 | 920,577 | 48.4% | 0.2% | |
| Ethnicity | White - British | 49.7% | 600,362 | 1,208,536 | 49.5% | 0.1% |
| White - Irish | 43.1% | 7,196 | 16,702 | 42.8% | 0.3% | |
| White - Any other White background | 39.5% | 17,052 | 43,169 | 39.3% | 0.2% | |
| Mixed - White and Black Caribbean | 39.6% | 854 | 2,156 | 39.3% | 0.3% | |
| Mixed - White and Black African | 37.7% | 427 | 1,134 | 37.7% | 0.0% | |
| Mixed - White and Asian | 40.1% | 525 | 1,309 | 40.1% | 0.0% | |
| Mixed - Any other mixed background | 39.8% | 903 | 2,268 | 39.2% | 0.6% | |
| Asian or Asian British - Indian | 39.6% | 10,115 | 25,550 | 39.3% | 0.2% | |
| Asian or Asian British - Pakistani | 40.6% | 4,298 | 10,591 | 39.5% | 1.1% | |
| Asian or Asian British - Bangladeshi | 42.7% | 1,246 | 2,919 | 41.7% | 1.0% | |
| Asian or Asian British - Any other Asian background | 37.0% | 4,235 | 11,431 | 36.8% | 0.2% | |
| Black or Black British - Caribbean | 36.0% | 4,116 | 11,431 | 35.2% | 0.9% | |
| Black or Black British - African | 31.6% | 2,541 | 8,050 | 30.7% | 0.9% | |
| Black or Black British - Any other Black background | 34.7% | 609 | 1,757 | 34.3% | 0.4% | |
| Other ethnic groups - Chinese | 36.6% | 1,162 | 3,178 | 36.1% | 0.4% | |
| Other ethnic groups - Any other ethnic group | 40.0% | 2,555 | 6,384 | 39.4% | 0.7% | |
| Patients with any other ethnicity code | 49.2% | 136,241 | 276,745 | 49.1% | 0.2% | |
| Ethnicity not stated | 48.2% | 5,656 | 11,725 | 48.1% | 0.2% | |
| Ethnicity not recorded | 49.1% | 159,544 | 325,080 | 48.9% | 0.2% | |
| Ethnicity (broad categories) | White | 49.2% | 624,624 | 1,268,428 | 49.1% | 0.1% |
| Mixed | 39.6% | 2,730 | 6,888 | 39.2% | 0.4% | |
| South Asian | 39.4% | 19,915 | 50,505 | 38.9% | 0.5% | |
| Black | 34.3% | 7,287 | 21,252 | 33.4% | 0.9% | |
| Other | 38.9% | 3,724 | 9,562 | 38.4% | 0.5% | |
| Unknown | 49.1% | 301,448 | 613,564 | 49.0% | 0.2% | |
| Index of Multiple Deprivation | 1 (most deprived) | 47.7% | 123,872 | 259,721 | 47.3% | 0.3% |
| 2 | 47.1% | 156,618 | 332,647 | 46.9% | 0.2% | |
| 3 | 48.8% | 204,694 | 419,461 | 48.6% | 0.2% | |
| 4 | 49.0% | 225,204 | 459,676 | 48.9% | 0.1% | |
| 5 (least deprived) | 49.9% | 241,353 | 483,399 | 49.8% | 0.1% | |
| Unknown | 52.2% | 7,987 | 15,288 | 52.0% | 0.3% | |
| Clinical Risk Groups | Patients in Any Clinical Risk Group | 49.4% | 573,223 | 1,159,865 | 49.2% | 0.2% |
| Patients with Immunosuppression | 49.2% | 42,168 | 85,722 | 49.0% | 0.2% | |
| Patients with CKD | 49.6% | 160,104 | 322,896 | 49.4% | 0.2% | |
| Patients who have Chronic Respiratory Disease | 50.3% | 112,826 | 224,133 | 50.1% | 0.2% | |
| Patients with Diabetes | 49.1% | 180,432 | 367,192 | 48.9% | 0.2% | |
| Patients with Chronic Liver disease | 48.6% | 25,375 | 52,164 | 48.5% | 0.2% | |
| Patients with CNS Disease (including Stroke/TIA) | 51.7% | 110,103 | 212,800 | 51.5% | 0.2% | |
| Patients with Chronic heart disease | 49.8% | 294,147 | 591,045 | 49.6% | 0.2% | |
| Patients with Asplenia or Dysfunction of the Spleen | 49.4% | 8,477 | 17,143 | 49.3% | 0.2% | |
| Patients with Wider Learning Disability | 58.6% | 1,365 | 2,331 | 57.4% | 1.2% | |
| Patients with Severe Mental Health | 51.6% | 8,141 | 15,792 | 51.0% | 0.5% | |
| Other Groups | Patients who are shielding (High Risk from COVID-19) | 49.8% | 153,286 | 307,671 | 49.6% | 0.3% |
| Patients with Morbid Obesity | 51.7% | 24,710 | 47,768 | 51.5% | 0.3% | |
| Patients who are pregnant | 53.1% | 119 | 224 | 53.1% | 0.0% |